Yong Rao

Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

Yong Rao, Zhiqi Kuang, Chan Li et al. · Gut Microbes · 2021 · 311 citations · Full text

Analogues of xanthones——Chalcones and bis-chalcones as α-glucosidase inhibitors and anti-diabetes candidates

Chao‐Yun Cai, Li Rao, Yong Rao et al. · European Journal of Medicinal Chemistry · 2017 · 96 citations

Medicinal Chemistry, α-Glucosidase Inhibitors, Biochemistry +6

Natural alkaloid bouchardatine ameliorates metabolic disorders in high‐fat diet‐fed mice by stimulating the sirtuin 1/liver kinase B‐1/AMPK axis

Yong Rao, Hong Yu, Lin Gao et al. · British Journal of Pharmacology · 2017 · 48 citations · Full text

Design, Synthesis, and Evaluation of New Quinazolinone Derivatives that Inhibit Bloom Syndrome Protein (BLM) Helicase, Trigger DNA Damage at the Telomere Region, and Synergize with PARP Inhibitors

Chenxi Wang, Zi-Lin Zhang, Qikun Yin et al. · Journal of Medicinal Chemistry · 2020 · 46 citations · Full text

Discovery of natural alkaloid bouchardatine as a novel inhibitor of adipogenesis/lipogenesis in 3T3-L1 adipocytes

Yong Rao, Hong Liu, Lin Gao et al. · Bioorganic & Medicinal Chemistry · 2015 · 45 citations

3T3-l1 Adipocytes, Novel Inhibitor, Biochemistry +4